TrialJournal of neurology2023

Efficacy and safety of clonidine for the treatment of impulse control disorder in Parkinson's disease: a multicenter, parallel, randomised, double-blind, Phase 2b Clinical trial.

Chloé Laurencin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.